Table 1
Permitted use of tumour necrosis factor (TNF) blocking agents in the European Union (EU) and the USA
Rheumatoid arthritis
Psoriatic arthritis
Ankylosing spondylitis
EU
USA
EU
USA
EU
USA
Adalimumab
√
√
√
Etanercept
√
√
√
√
√
√
Infliximab
√
√
√
√
√